News GNI Group Ltd.

Equities

2160

JP3386370005

Delayed Japan Exchange Other stock markets 02:00:00 2024-06-12 am EDT			5-day change	1st Jan Change
2,247 ^JPY	-0.27%		+3.93%	-20.60%

May. 31	Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	MT
Mar. 19	Jefferies Adjusts GNI Group’s Price Target to 4,100 Yen From 3,000 Yen, Keeps at Buy	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	May. 31	MT
Jefferies Adjusts GNI Group’s Price Target to 4,100 Yen From 3,000 Yen, Keeps at Buy	Mar. 19	MT
GNI Group Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending December 2024	Feb. 14	CI
Jefferies Upgrades GNI to Buy From Hold, Adjusts Price Target to 3,000 Yen From 1,500 Yen	Nov. 17	MT
GNI Group Revises Fiscal 2023 Forecast Upwards after Subsidiaries Show Better-than-Expected Sales, Foreign Exchange Rates	Nov. 05	MT
GNI Group Ltd. Revises Consolidated Earnings Guidance for the Full Year Ending December 31, 2023	Nov. 05	CI
GNI Group Ltd. Announces New Management Structure	23-09-28	CI
GNI Group Ltd. Announces New Management Structure	23-09-28	CI
GNI Group Plans to Buy Portion of Elutia's Orthobiologics Business	23-09-20	MT
Wall Street Set to Open Marginally Lower as Fed Kicks Off September Policy Meeting	23-09-19	MT
Equity Futures Trend Higher as Investors Expect No Rate Hike From Fed	23-09-19	MT
North American Morning Briefing : Stock Futures Lack Momentum as Fed Decision Looms	23-09-19	DJ
Elutia Sells Orthobiologics Business Unit For Up to $35 Million	23-09-18	MT
GNI Group issues 1,350 Stock Acquisition Rights	23-09-12	MT
GNI Group to Issue 1,350 Stock Options; Shares Up 3%	23-08-28	MT
GNI Subsidiary Cullgen Closes Series C Funding	23-08-23	MT
GNI Group Ltd. Revises Consolidated Earnings Guidance for the Year Ending December 31, 2023	23-08-03	CI
GNI Group Invests in Shanghai JIUCE Medical Device Technology via Subsidiary	23-08-02	MT
GNI Completes Investment in Shanghai JIUCE for China Expansion	23-08-02	MT
Gni Group Ltd. Announces Notice of Executive Officer Appointment	23-07-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GNI Group Ltd.

Equities

2160

JP3386370005

Summary

Filters